Atacand
Links shared publicly online about this topic
Not All Heart Failure Drugs Boost Survival Equally - Drugs.com MedNews
drugs.com — “Over the course of five years, heart failure patients taking the blood pressure drug candesartan stood a higher chance of survival than those taking losartan di” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 10:02 pm By:
Drugs and Devices OW OW Health
Not All Heart Failure Drugs Boost Survival Equally: TUESDAY, Jan. 11 -- Over the course of five years, hea... http://bit.ly/gVl0bT #drug
Not All Heart Failure Drugs Boost Survival Equally - Drugs.com MedNews
drugs.com — “Over the course of five years, heart failure patients taking the blood pressure drug candesartan stood a higher chance of survival than those taking losartan di” View full resource at drugs.com
Most Recently Shared on January 12, 2011 at 12:40 am By:
Not All Heart Failure Drugs Boost Survival Equally - http://bit.ly/e78zKT
Medical News: CHF Registry Shows Survival Difference With ARBs - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Heart failure patients lived significantly longer when treated with candesartan (Atacand) than with losartan, data from a patient registry showed.” View full resource at medpagetoday.com
Most Recently Shared on January 11, 2011 at 11:04 pm By:
CHF Registry Shows Survival Difference With ARBs (CME/CE, with audio) http://bit.ly/geMyOB
Medical News: HFC: Registry Data Suggest Survival Benefit for Candesartan - in Meeting Coverage, HFC from MedPage Today
medpagetoday.com — “BERLIN -- Systolic heart failure patients treated with candesartan (Atacand) had better one-year survival than those taking losartan (Cozaar) -- regardless of dose, comorbidities, or background heart” View full resource at medpagetoday.com
Most Recently Shared on May 31, 2010 at 10:16 am By:
HFC: Registry Data Suggest Survival Benefit for Candesartan (CME/CE) http://ow.ly/17yPgv
Blood Pressure Drugs Might Fight Diabetic Retinopathy - Drugs.com MedNews
drugs.com — “New research in mice suggests that some drugs used to treat high blood pressure might help prevent and treat a disorder that causes people with diabetes to lose” View full resource at drugs.com
Most Recently Shared on January 9, 2010 at 12:07 am By:
Blood Pressure Drugs Might Fight Diabetic Retinopathy - http://bit.ly/4CxUvy
FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk
drugs.com — “FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk” View full resource at drugs.com
Most Recently Shared on July 16, 2010 at 12:22 am By:
FDA Alert - Angiotensin Receptor Blockers: Ongoing Safety Review for Cancer Risk - http://bit.ly/b2MJfG
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk Information on Healthline
healthline.com — “Read about Blood Pressure, and other breaking health care stories in the Health Day News section of Healthline.” View full resource at healthline.com
Most Recently Shared on June 14, 2010 at 9:36 pm By:
#heartdisease Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk http://w.sns.ly/r3x40 #heart
Telmisartan (Micardis) Drug Information by MedicineNet.com
medicinenet.com — “Telmisartan (micardis) is an arb prescribed for the treatment of high blood pressure and the prevention of heart attack, stroke, and cardiovascular events in patients at risk.” View full resource at medicinenet.com
Most Recently Shared on January 7, 2010 at 6:45 pm By:
MedicineNet: telmisartan, Micardis http://bit.ly/64aggw Full http://bit.ly/7AQcW1
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk: SUNDAY, June 13 (HealthDay News) -- Use of a pop... http://bit.ly/allfwY
health.yahoo.net — “Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk: SUNDAY, June 13 (HealthDay News) -- Use of a pop... http://bit.ly/allfwY” View full resource at health.yahoo.net
Most Recently Shared on June 13, 2010 at 11:31 pm By:
Jennifer Ann Grisso Nurse and Active Health Library
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk: SUNDAY, June 13 (HealthDay News) -- Use of a pop... http://bit.ly/allfwY
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk:
health.msn.com — “Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk:” View full resource at health.msn.com
Most Recently Shared on June 13, 2010 at 11:40 pm By:
Popular Blood Pressure Drugs Tied to Slight Rise in Cancer Risk: http://bit.ly/cqy4lH
Blood Pressure Drugs Might Fight Diabetic Retinopathy:
health.msn.com — “Blood Pressure Drugs Might Fight Diabetic Retinopathy:” View full resource at health.msn.com
Most Recently Shared on January 8, 2010 at 5:50 pm By:
Blood Pressure Drugs Might Fight Diabetic Retinopathy: http://bit.ly/6QjHAY
Not All Heart Failure Drugs Boost Survival Equally - MSN Health - High Blood Pressure
health.msn.com — “Comparison study found patients taking candesartan outlived those on losartan” View full resource at health.msn.com
Most Recently Shared on January 11, 2011 at 9:51 pm By:
Not All Heart Failure Drugs Boost Survival Equally: http://on-msn.com/g3nzxH
Medical News: CHF Registry Shows Survival Difference With ARBs - in Cardiovascular, CHF from MedPage Today
medpagetoday.com — “Heart failure patients lived significantly longer when treated with candesartan (Atacand) than with losartan, data from a patient registry showed.” View full resource at medpagetoday.com
Most Recently Shared on January 12, 2011 at 4:49 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Heart failure patients live significantly longer when treated with candesartan than with losartan: http://bit.ly/hsW0rc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement
